This site is for US consumers.
This site is for US consumers.Prescribing info

NOW APPROVED FOR ADULTS AGED 60 OR OLDER

Protect yourself against RSV with
mRESVIA by Moderna

mRESVIA is used to protect adults aged 60 or older against lower respiratory tract disease
caused by respiratory syncytial virus (RSV).

Share this site
Copy link

RSV risk for older adults

RSV stands for respiratory syncytial (sin-SISH-uhl) virus, a highly contagious virus that can affect your lungs and breathing passages.

If you’re aged 60 or older, the risk of RSV infection causing severe symptoms can be even higher—making it that much more important to protect yourself. If you got sick with RSV, you’d miss out on being there for the ones you love.

For some people, RSV infection can lead to more serious and potentially life-threatening illnesses. RSV can be especially risky for older adults with certain medical conditions like:

Chronic obstructive pulmonary disease

(COPD)

Asthma

Congestive heart failure

(CHF)

Advanced liver or kidney disease

Diabetes

Introducing mRESVIA to protect against RSV

mRESVIA is a vaccine that protects against lower respiratory tract disease caused
by RSV in adults aged 60 or older.

Ask your doctor or pharmacist about mRESVIA.

We're here to help

Get in touch with questions or for any information you may need.

Email us

WeCare@modernatx.com

Call us

1-866-MODERNA (1-866-663-3762) 8:00 AM - 8:00 PM ET Monday - Friday (closed holidays)

Learn more about us

www.ModernaTX.com
What is mRESVIA and Important Safety Information

What is mRESVIA® (Respiratory Syncytial Virus Vaccine)?

mRESVIA is a vaccine to protect you against lower respiratory tract disease caused by Respiratory Syncytial Virus (RSV).

mRESVIA is for people 60 years of age and older. Vaccination with mRESVIA may not protect all people who receive the vaccine.

mRESVIA does not contain RSV. mRESVIA cannot give you lower respiratory tract disease caused by RSV.

Important Safety Information

Who should not get mRESVIA?

You should not get mRESVIA if you had a severe allergic reaction to any ingredient in mRESVIA.

What should you tell your healthcare provider?

Tell your healthcare provider about all of your medical conditions, including if you:

  • Have any allergies
  • Had a severe allergic reaction after receiving a previous dose of any other vaccine
  • Have a fever
  • Have a bleeding disorder or are on a blood thinner
  • Are immunocompromised or are on a medicine that affects your immune system
  • Have received any other RSV vaccine
  • Have ever fainted in association with an injection
How is mRESVIA given?

mRESVIA is given as an injection into the muscle.

What are the risks of mRESVIA?

There is a very small chance that mRESVIA could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of mRESVIA. For this reason, your healthcare provider may ask you to stay for a short time at the place where you received your vaccine. Signs of a severe allergic reaction may include:

  • Trouble breathing
  • Swelling of your face and throat
  • A fast heartbeat
  • A rash all over your body
  • Dizziness and weakness

Side effects that have been reported in clinical trials with mRESVIA include:

  • Injection-site reactions: pain, underarm swelling or tenderness in the same arm of the injection, swelling (hardness), and redness
  • Fatigue, headache, muscle pain, joint pain, chills, nausea or vomiting, fever and hives

These may not be all of the possible side effects of mRESVIA. Ask your healthcare provider about any side effects that concern you. You may report side effects to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or www.vaers.hhs.gov.

Please click for mRESVIA Full Prescribing Information.

Helpful Links
Visit the Healthcare Professionals site
About Moderna
Connect with Us
Report a side effect:
Adverse Event Intake Portal
Terms and ConditionsPrivacy Statement

© 2024 Moderna US-RSV-2400010 05/2024